This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Randomized Phase II Study of the Anti-inflammatory Effect of Ghrelin During the Postoperative Period of Esophagectomy

Tuesday, July 14, 2015

Submitted by


Takata, Akihiro; Takiguchi, Shuji; Miyazaki, Yasuhiro; Miyata, Hiroshi; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Yamasaki, Makoto; Nakajima, Kiyokazu; Mori, Masaki; Kangawa, Kenji; Doki, Yuichiro

This small randomized trial evaluated the potential benefits of ghrelin, an anti-inflammatory agent, in reducing the SIRS response after esophagectomy.  The ghrelin group had a reduced SIRS duration, lower CRP levels, and lower IL-6 levels compared to controls.  Pulmonary complications were reduced in the ghrelin group, but other complication incidences were similar.

Add comment

Log in or register to post comments